Gene and Cell Therapy – Multimedia

Interest in CGT&RMs has grown alongside the pharmaceutical and biotechnology industries in recent years; Japan’s established, rapidly expanding market makes it the perfect location to facilitate successful CGT&RM programs. `

Metabolism is a key driver of CAR-T cell fitness and function. Hence, metabolic preconditioning methods can enhance the bioenergetic capacity of CAR-T cells in culture, supporting their persistence and antitumor activity

In this informative video, you will discover the latest technologies and workflows used in the field of cell and gene therapy.

Adeno-associated viruses (AAVs) are considered one of the most effective and safe ways to deliver therapeutic genes for the treatment of a wide range of genetic conditions.

Metabolism has emerged as a key driver of T-cell antitumor function. This means that modulating metabolic programs of T cells can be used as a strategy to improve the antitumor efficacy of adoptive T-cell therapies.

The scale of research into potential gene therapies often means that work is distributed across multiple locations. Investigators must have confidence that the results obtained at one site are consistent with results obtained at other sites participating in the study.

Whether your key vector strategy is based on adenoviruses (AV), adeno-associated viruses (AAV) or lentiviruses (LV), the development of these genetic analysis tools is enabling researchers to develop safer gene therapies – with greater speed.

In this infographic, we explore the latest advances in gene therapy, including production and delivery mechanisms.

Speaking at the Advances in Drug Discovery & Development 2022 online symposium, Leonardo Ferreira discusses how engineering human regulatory T cells can protect against an immune attack in type 1 diabetes.

Greater appreciation for the complex and dynamic connections between metabolic poise and immune cell function enables researchers to monitor and control how metabolic reprogramming